Prevalence and correlates of the misuse of z-drugs and benzodiazepines in the National Survey on Drug Use and Health

被引:10
|
作者
McHugh, R. Kathryn [1 ,2 ]
Votaw, Victoria R. [3 ,4 ]
Trapani, Emma W. [1 ]
McCarthy, Megan D. [1 ]
机构
[1] McLean Hosp, Div Alcohol Drugs & Addict, Belmont, MA 02478 USA
[2] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA
[3] Univ New Mexico, Dept Psychol, Albuquerque, NM USA
[4] Univ New Mexico, Ctr Alcohol Subst Use & Addict, Albuquerque, NM USA
来源
FRONTIERS IN PSYCHIATRY | 2023年 / 14卷
关键词
benzodiazepines; z-drugs; sedatives; prescription drug misuse; sedative; anxiolytic use disorder; ABUSE LIABILITY; ALPRAZOLAM; ZOLPIDEM; ALCOHOL; PRESCRIPTIONS; TRIAZOLAM; ZOPICLONE; HUMANS;
D O I
10.3389/fpsyt.2023.1129447
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
BackgroundBenzodiazepines and non-benzodiazepine hypnotics (z-drugs) are commonly prescribed for their anxiolytic and hypnotic properties, though they can also be misused. In studies examining the epidemiology of prescription drug misuse, these medication classes are commonly combined, rendering inadequate knowledge of their patterns of misuse. The objective of this study was to characterize the population prevalence, conditional dependence, and sociodemographic and clinical correlates of the misuse of benzodiazepines and z-drugs. MethodsData from the National Survey on Drug Use and Health from 2015 to 2019 were used to estimate population-level prevalence and characteristics of benzodiazepine and z-drug misuse. Groups were derived based on past-year misuse of benzodiazepines alone, z-drugs alone, or both drug types. Unadjusted regression analyses were used to compare groups on characteristics of interest. ResultsExposure to benzodiazepines and/or z-drugs via prescription or misuse was common; however, only 2% of the population was estimated to have misused a benzodiazepine in the past year, and less than 0.5% misused z-drugs. People who misused only z-drugs were generally older, more likely to have health insurance, more educated, and had less severe psychiatric symptoms. This group was also more likely to report misuse to cope with sleep difficulty. Although concurrent substance use was highly prevalent in all groups, people who misused z-drugs alone generally reported less concurrent substance use than the other groups. ConclusionThe misuse of z-drugs is less common than benzodiazepines, and people who misuse only z-drugs appear to generally have lower clinical severity. Nonetheless, a substantial subgroup of people exposed to z-drugs report concurrent, past-year use of other substances. Further research on z-drug misuse, including consideration of whether it should be grouped with other anxiolytic/hypnotic drugs, is needed.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] The use of a national identification system to prevent misuse of benzodiazepines and Z-drugs in Japan
    Kinoshita, Shotaro
    Kishimoto, Taishiro
    LANCET PSYCHIATRY, 2023, 10 (10): : E26 - E26
  • [2] Misuse of benzodiazepines and Z-drugs in the UK
    Kapil, V.
    Green, J. L.
    Le Lait, C.
    Wood, D. M.
    Dargan, P. I.
    BRITISH JOURNAL OF PSYCHIATRY, 2014, 205 (05) : 407 - 408
  • [3] Prevalence of Use, Abuse and Dependence: Benzodiazepines, Z-drugs and Prescription Opioids
    Wolter, Dirk
    SUCHTTHERAPIE, 2020, 21 (02) : 66 - 75
  • [4] Use and misuse of benzodiazepines and z-drugs in the French psychiatric population, an in-patients cohort
    Panes, A.
    Pariente, A.
    Fourrier-Reglat, A.
    Berdrai, D.
    Tournier, M.
    EUROPEAN PSYCHIATRY, 2018, 48 : S449 - S449
  • [5] Use of Benzodiazepines and Z-Drugs in Multiple Sclerosis
    Marrie, Ruth Ann
    Fisk, John D.
    Walld, Randy
    Bolton, James M.
    Sareen, Jitender
    Patten, Scott B.
    Singer, Alexander
    Lix, Lisa M.
    Hitchon, Carol A.
    El-Gabalawy, Renee
    Katz, Alan
    Marriott, James J.
    Bernstein, Charles N.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [6] Nonmedical use of benzodiazepines and Z-drugs in the UK
    Hockenhull, Joanna
    Black, Joshua C.
    Haynes, Colleen M.
    Rockhill, Karilynn
    Dargan, Paul I.
    Dart, Richard C.
    Wood, David M.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (04) : 1676 - 1683
  • [7] Use of Benzodiazepines and Z-Drugs in Nursing Home Residents with Dementia: Prevalence and Appropriateness
    Rijksen, Dirk O. C.
    Zuidema, Sytse U.
    de Haas, Esther C.
    JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2021, 5 (01) : 871 - 879
  • [8] Use of Benzodiazepines and Z-Drugs in Inflammatory Bowel Disease
    Bernstein, Charles N. N.
    Fisk, John D. D.
    Walld, Randy
    Bolton, James M. M.
    Sareen, Jitender
    Patten, Scott B. B.
    Singer, Alexander
    Lix, Lisa M.
    Hitchon, Carol A. A.
    El-Gabalawy, Renee
    Graff, Lesley A. A.
    Katz, Alan
    Witges, Kelcie
    Marriott, James J. J.
    Marrie, Ruth Ann
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (12): : 2046 - 2054
  • [9] An online survey on misuse of benzodiazepines and "Z drugs" in Singapore
    Chan, Wui Ling
    Wood, David M.
    Haynes, Colleen M.
    Rockhill, Karilynn M.
    Green, Jody L.
    Dargan, Paul I.
    CLINICAL TOXICOLOGY, 2017, 55 (05) : 441 - 442
  • [10] Presentations to the Emergency Department with misuse of benzodiazepines and Z-drugs: profiling and relation to sales data
    Lyphout, Cathelijne
    Yates, Christopher
    Dugan, Paul I.
    Margolin, Zachary R.
    Dines, Alison
    Heyerdahl, Fridtjof
    Hovda, Knut Erik
    Giraudon, Isabelle
    Bartelson, Becki
    Green, Jody L.
    Wood, David M.
    CLINICAL TOXICOLOGY, 2018, 56 (06) : 471 - 472